Beyond DNA—CRISPR technologies for epigenome editing and transcriptional regulation in disease: A scoping review
CRISPR‐derived epigenome editors enable locus‐specific control of gene expression without changing the underlying DNA sequence, creating therapeutic opportunities for dosage‐sensitive disorders, imprinting diseases, aberrant gene activation and reversible cell‐state engineering. This scoping review maps me...